Phase 2 Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older.
- You have been diagnosed with a specific type of low-grade bladder cancer (called low-grade Ta urothelial carcinoma), which is either returning after a previous occurrence, a single tumor larger than 3 cm, or multiple tumors present at the same time (up to 10% high-grade cells are allowed).
- You are generally able to carry out daily activities, with only mild limitations at most (confirm with trial site).
- Scans or imaging have shown no signs of cancer in the upper urinary tract (kidneys or ureters).
- A bladder examination (cystoscopy) has shown no cancer in the urethra (the tube that carries urine out of the body).
- A bladder examination within the past 60 days has shown no visible tumors remaining.
- Your blood test shows a healthy enough level of white blood cells (neutrophils ≥ 1,500 cells/mm³).
- Your blood test shows a healthy enough level of platelets (> 100,000 cells/mm³).
- If you have or have had another type of cancer, you may still be eligible if your doctor determines it would not interfere with this trial.
- If you are able to become pregnant, you must agree to use effective birth control during the study and for at least 6 months after the last dose of the study treatment.
- If your partner can become pregnant, you must agree to use approved contraception during the study and for at least 3 months after the last dose of the study treatment.
- You must be willing to sign a consent form and agree to follow all study procedures.
Who may not be able to join:
- You have a history of high-grade bladder cancer or high-grade cancer in your upper urinary tract.
- You have previously been treated with a bladder treatment called BCG (a common immunotherapy given directly into the bladder).
- Your bladder cancer is a specific type called pure squamous cell carcinoma or adenocarcinoma.
- Your cancer includes any component of a type called neuroendocrine carcinoma.
- You have a physical condition that makes it impossible to insert a urinary catheter.
- Your bladder is too small to receive treatment delivered directly into the bladder, as determined by your urologist.
- You are able to become pregnant but are unwilling or unable to use acceptable birth control for the full study period and for at least 6 months after the last dose.
- You are currently pregnant or breastfeeding.
- You have another serious health condition that your doctor believes could make the treatment unsafe or affect the study results.
- You have received a vaccine containing a live virus within 30 days before starting the trial (for example, the nasal spray flu vaccine FluMist — note that most standard flu shots do not contain live virus and may be acceptable; confirm with trial site).
- You are currently in prison, held in a facility against your will, or are being detained for treatment of a mental health or physical health condition.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paul Crispen, MD, University of Florida
Phone: 352-294-5018
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrence free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.